GELS

Healthcare Drug Manufacturers - Specialty & Generic

Gelteq Limited

$0.54

+0.01 +2.31% today

Price History

Not enough data

Key Stats

Market Cap

5.83M

Avg Volume

2.82M

EPS

-$0.44

52W High

$2.01

52W Low

$0.39

Div. Yield

0.0%

Valuation

P/B Ratio

0.61

P/S Ratio

12.34

EV/EBITDA

-2.18

EV/Revenue

23.71

Margins

Gross Margin 75.5%

Operating Margin (1985.3%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

48.9%

Return on Equity

(42.9%)

Return on Assets

(17.6%)

Liquidity & Leverage

Current Ratio

0.09

Quick Ratio

0.07

Debt / Equity

0.36

Total Cash

9,349

Total Debt

5.11M

About

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.